Affinage

ISL2

Insulin gene enhancer protein ISL-2 · UniProt Q96A47

Length
359 aa
Mass
39.8 kDa
Annotated
2026-04-28
11 papers in source corpus 7 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ISL2 is a LIM-homeodomain transcription factor that controls motor neuron circuit organization and acts as a context-dependent regulator of angiogenesis and metabolism in cancer. Its homeodomain binds TAAT-containing DNA consensus sequences (C/TTAATG/TG/A and C/TTAAGTG), while its LIM domains coordinate zinc but do not inhibit DNA binding, and the protein forms physical complexes with other LIM-HD factors such as Lhx4 (PMID:7999775, PMID:19194008). In the spinal cord, ISL2 is required for motor pool organization, Etv4 expression in hindlimb motor neurons, terminal axon branching, neuromuscular junction integrity, and sensorimotor circuit connectivity (PMID:37869988). In glioma, ISL2 directly activates the VEGFA and ANGPT2 promoters to drive angiogenesis through a cARF1/miR-342-3p/U2AF2 feedback loop, whereas in pancreatic ductal adenocarcinoma it functions as a tumor suppressor whose loss elevates oxidative phosphorylation and confers sensitivity to mitochondrial complex I inhibitors (PMID:32894165, PMID:32753650, PMID:35508175).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 1994 High

    Defining which domains mediate DNA binding resolved a key question about LIM-homeodomain architecture: unlike rat Isl-1, the LIM domains of ISL2 do not auto-inhibit DNA binding, establishing the homeodomain as the autonomous TAAT-sequence recognition module.

    Evidence Zinc blot, EMSA, SELEX, and Scatchard analysis with domain-deletion GST fusions of salmon Isl-2

    PMID:7999775

    Open questions at the time
    • No in vivo target genes identified
    • Transcriptional activation versus repression capacity not tested
    • Structural basis of LIM-homeodomain interplay unresolved
  2. 2004 Medium

    Demonstration that axolotl ISL2 activates the insulin gene promoter confirmed that ISL2 functions as a transcriptional activator, extending its conserved role beyond DNA binding to gene regulation.

    Evidence DNA binding and transcriptional reporter assays with axolotl ISL2 on the rat insulin promoter

    PMID:15048808

    Open questions at the time
    • Single reporter system without mutagenesis of binding sites
    • Endogenous target genes in ISL2-expressing tissues not identified
    • Cofactor requirements for activation unknown
  3. 2009 Medium

    Crystallization of the Lhx4-LIM/Isl2 peptide complex revealed that ISL2 forms stable protein-protein interactions with other LIM-HD factors, suggesting a mechanism for combinatorial transcriptional regulation.

    Evidence Protein co-expression, purification, and X-ray crystallography to 2.16 Å resolution

    PMID:19194008

    Open questions at the time
    • No functional validation of the complex in transcription assays
    • In vivo relevance of the Lhx4-Isl2 interaction not tested
    • Whether this interaction is required for motor neuron development unknown
  4. 2020 High

    Identification of VEGFA and ANGPT2 as direct transcriptional targets of ISL2 in glioma established ISL2 as a pro-angiogenic driver, with a cARF1/miR-342-3p/U2AF2 feedback loop sustaining its expression under hypoxia.

    Evidence ChIP on VEGFA and ANGPT2 promoters, dual-luciferase reporters, RIP, RNA pull-down, shRNA knockdown, tube formation assays in GSCs/hBMECs, and orthotopic xenograft models

    PMID:32753650 PMID:32894165

    Open questions at the time
    • Genome-wide binding profile of ISL2 in glioma cells not determined
    • Whether ISL2 angiogenic function extends beyond CNS tumors is unknown
    • Direct versus indirect regulation of downstream angiogenic cascades not fully dissected
  5. 2022 High

    CRISPR screening in pancreatic cancer revealed that ISL2 suppresses tumor growth by restraining oxidative phosphorylation, demonstrating a context-dependent tumor-suppressive role opposite to its oncogenic function in glioma.

    Evidence In vivo CRISPR screening, CRISPRa endogenous upregulation, spatial transcriptomics, metabolic assays, and mitochondrial complex I inhibitor sensitivity testing in PDA models

    PMID:35508175

    Open questions at the time
    • Direct metabolic target genes of ISL2 in PDA not fully mapped by ChIP
    • Mechanism by which ISL2 loss shifts metabolism toward OXPHOS not resolved at the molecular level
    • Whether tumor-suppressive function applies to other gastrointestinal cancers untested
  6. 2023 High

    Knockout of Isl2 in mice demonstrated its essential role in motor pool organization, axon branching, neuromuscular junction formation, and sensorimotor connectivity, providing the first in vivo loss-of-function characterization of ISL2 in neural circuit assembly.

    Evidence Isl2 knockout mice analyzed by immunohistochemistry, spinal cord transcriptomics, NMJ imaging, and locomotion behavioral assays

    PMID:37869988

    Open questions at the time
    • Direct genomic targets mediating motor pool specification not identified by ChIP-seq
    • Relative contributions of ISL2 versus ISL1 in overlapping motor neuron populations unresolved
    • Whether ISL2 acts through the Lhx4 complex in vivo for motor pool patterning is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • The genome-wide direct target repertoire of ISL2 in both neural and cancer contexts, the structural basis of its context-dependent activator versus suppressor roles, and whether the Lhx4-ISL2 complex is functionally relevant in vivo remain unresolved.
  • No genome-wide ChIP-seq for ISL2 in motor neurons or pancreatic cells
  • Structural determinants of tissue-specific cofactor selection unknown
  • Functional significance of the Lhx4-ISL2 complex in any physiological context untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 5 GO:0140110 transcription regulator activity 5
Localization
GO:0005634 nucleus 1 GO:0005694 chromosome 1
Pathway
R-HSA-74160 Gene expression (Transcription) 5 R-HSA-1643685 Disease 3 R-HSA-112316 Neuronal System 1 R-HSA-1266738 Developmental Biology 1
Partners
ANGPT2LHX4U2AF2VEGFA

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1994 ISL2 LIM domains bind zinc, while the homeodomain (not LIM domains) is responsible for DNA binding to TAAT target sequences; full-length ISL2 binds two consensus sequences (C/TTAATG/TG/A and C/TTAAGTG) with similar affinity to the homeodomain alone, indicating LIM domains do not inhibit DNA binding in salmon Isl-2 (unlike rat Isl-1). Zinc blot analysis, gel-shift assay (EMSA), SELEX, Scatchard analysis using GST fusion proteins with full-length or truncated Isl-2 Biochemistry High 7999775
2004 Axolotl ISL2 binds the rat insulin gene promoter and induces transcription from it, demonstrating conserved transcriptional activation function of ISL2 across species. DNA binding assay and transcriptional reporter assay in functional tests Genesis (New York, N.Y. : 2000) Medium 15048808
2009 The LIM domains of the LIM-homeodomain protein Lhx4 form a stable intramolecular complex with a peptide region of Isl2, and this complex was crystallized and diffracted to 2.16 Å resolution, establishing a physical interaction between Lhx4 LIM domains and Isl2. Protein engineering, purification, and X-ray crystallography Acta crystallographica. Section F, Structural biology and crystallization communications Medium 19194008
2020 ISL2 transcriptionally regulates VEGFA expression in glioma stem cells and promotes proliferation, invasion, and angiogenesis of human brain microvessel endothelial cells via VEGFA-mediated ERK signaling; upstream regulation involves cARF1 sponging miR-342-3p to upregulate ISL2, and ISL2 in turn induces U2AF2, which stabilizes cARF1, forming a feedback loop. ChIP assay (ISL2 binding to VEGFA promoter), dual-luciferase reporter, RNA-binding protein immunoprecipitation, RNA pull-down, lentiviral knockdown/overexpression, tube formation and Transwell assays in GSCs and hBMECs Journal of experimental & clinical cancer research : CR High 32894165
2020 ISL2 promotes oligodendroglioma angiogenesis and malignant transformation by binding to the ANGPT2 promoter to transcriptionally activate ANGPT2, which then activates angiogenesis through VEGFA; hypoxia induces ISL2 expression, creating a positive feedback loop. ChIP assay (ISL2 binding to ANGPT2 promoter), orthotopic xenograft mouse models, shRNA knockdown, in vitro proliferation and angiogenesis assays Oncogene High 32753650
2022 ISL2 acts as a tumor suppressor in pancreatic ductal adenocarcinoma; it is a nuclear and chromatin-associated transcription factor that regulates metabolic gene expression, and its depletion increases oxidative phosphorylation (OXPHOS), rendering ISL2-depleted PDA cells sensitive to mitochondrial complex I inhibitors. In vivo CRISPR screening, CRISPR-mediated endogenous upregulation, exogenous ISL2 expression, spatial transcriptomics, metabolic assays, in vitro and in vivo inhibitor sensitivity testing Developmental cell High 35508175
2023 Isl2 controls motor pool organization in the spinal cord; deletion of Isl2 in mice causes dispersion of median and lateral motor column pools, loss of Etv4 expression in hindlimb motor pools, reduced terminal axon branching, disorganized neuromuscular junctions, and impaired sensorimotor connectivity and hindlimb locomotion; transcriptomic analysis identified downregulated genes associated with MN differentiation, axon development, and synapse organization. Isl2 knockout mouse model, immunohistochemistry, transcriptomic analysis of spinal cord, neuromuscular junction imaging, locomotion behavioral assays eLife High 37869988

Source papers

Stage 0 corpus · 11 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2020 The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells. Journal of experimental & clinical cancer research : CR 94 32894165
2006 Early identification of retinal subtypes in the developing, pre-laminated chick retina using the transcription factors Prox1, Lim1, Ap2alpha, Pax6, Isl1, Isl2, Lim3 and Chx10. European journal of histochemistry : EJH 59 16864127
2010 Sperry versus Hebb: topographic mapping in Isl2/EphA3 mutant mice. BMC neuroscience 20 21190559
1994 Zinc and DNA binding properties of a novel LIM homeodomain protein Isl-2. Biochemistry 19 7999775
2020 ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma. Oncogene 17 32753650
2022 ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Developmental cell 16 35508175
2006 Cloning and expression of a novel human gene, Isl-2, encoded a LIM-homeodomain protein. Molecular biology reports 10 17091338
2023 Transcriptional control of motor pool formation and motor circuit connectivity by the LIM-HD protein Isl2. eLife 8 37869988
2004 Cloning and analysis of axolotl ISL2 and LHX2 LIM-homeodomain transcription factors. Genesis (New York, N.Y. : 2000) 7 15048808
2009 Crystallization and diffraction of an Lhx4-Isl2 complex. Acta crystallographica. Section F, Structural biology and crystallization communications 5 19194008
2022 Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma. Frontiers in oncology 0 35965581